Clinical Trials Directory

Trials / Completed

CompletedNCT05130671

Nutritional Supplementation of Flavonoids Quercetin and Curcumin for Early Mild Symptoms of COVID-19

Treatment Benefits of Flavonoids Quercetin and Curcumin Supplements for Mild Symptoms of COVID-19

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
King Edward Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the therapeutic benefits of flavonoids nutritional supplements quercetin and curcumin for early mild symptoms of COVID-19.

Detailed description

Flavonoids nutritional supplements quercetin and curcumin have demonstrated strong antioxidant, broad-spectrum anti-viral and anti-inflammatory properties including against the respiratory tract infections. They are widely used to boost the immunity against infections and keeping healthy life-style. Results from recent published studies have shown positive results for quercetin and curcumin in patients with COVID-19. In the present study the investigators aim to study the combined beneficial effects of quercetin and curcumin in addition to standard of care for managing early mild symptoms of COVID-19 in community-based patients.

Conditions

Interventions

TypeNameDescription
DRUGStandard of careStandard of care treatment as per the hospital guidelines
DIETARY_SUPPLEMENTInvestigational treatmentCombination of quercetin and curcumin as add-on to the standard of care

Timeline

Start date
2021-10-25
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2021-11-23
Last updated
2022-01-28

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05130671. Inclusion in this directory is not an endorsement.